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Abstract 
Prevalence and injury risk of driving with alcohol, illicit drugs and medicines have been estimated as part of the 
DRUID (Driving under the Influence of Drugs, Alcohol and Medicines) project of FP6. 
Prevalence in the driving population was based on roadside surveys in thirteen European countries, prevalence in 
seriously injured drivers and killed drivers on data from nine countries. Blood and/or saliva samples were collected 
and analysed for ethanol, amphetamines, cocaine, cannabis, illicit opiates, benzodiazepines, Z-drugs and medicinal 
opioids. The estimates were based on concentrations at and above equivalent cut-offs in blood and saliva, enabling 
the inclusion of both blood and saliva in the calculations. Drivers in traffic served as the control sample and seriously 
injured/killed drivers as the case sample for estimating the risk as calculated by means of odds ratios, adjusted for age 
and gender.  
The alcohol prevalence (concentrations ≥ 0.1 g/L) was much higher than the prevalence of other drugs, with highest 
alcohol prevalence in all three study samples in the southern and western European countries. Combined alcohol/drug 
use and multiple drug use were far more common in accident-involved drivers than in drivers in traffic. The 
prevalence of other drugs was highest in the driving population in south Europe with THC as most common, whereas 
benzodiazepines dominated in the northern countries of Europe.  
Based on data from all involved countries, the risk of being seriously injured or killed significantly exceeded 1 for 
alcohol concentrations ≥ 0.5 g/L and almost all other drugs. Odds ratios differ between age groups and countries, but 
overall, alcohol concentrations ≥ 1.2 g/L together with combined alcohol/drug use had the highest odds-ratios, 
followed by alcohol concentrations between 0.8 and 1.2 g/L and multiple drug use.  
 
© 2011 Published by Elsevier Ltd. Selection and peer-review under responsibility of TRA 2012 
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1. Introduction 
1.1. Background 
The use of psychoactive substances can influence people’s motor and cognitive performance (OECD, 
2010 and references therein), and, consequently, be a hazard to traffic safety. Alcohol is a well-known 
contributor to road accidents (Borkenstein et al., 1974, Elvik and Vaa, 2004, Assum, 2005, Krüger and  
Vollrath, 2004) but other substances, such as illicit drugs and psychoactive medicines, can also adversely 
affect the fitness to drive (Berghaus, 2011) and, therefore, endanger traffic safety. 
1.2. Objectives 
The objectives of this paper are to assess the prevalence in the general driving population in European 
countries and in drivers who have been seriously injured or killed in traffic accidents as well as to assess 
the risk of driving with alcohol, illicit drugs and medicinal drugs. Furthermore the objective is to reveal 
whether there are differences in prevalence and risk between countries. 
In total thirteen countries took part in the study of prevalence in the general driving population, of 
which nine countries took part in the study of the prevalence of seriously injured/killed drivers. These 
nine countries also participated to the study on relative risk of serious injury/fatality while positive for 
psychoactive substances. The studies are part of the DRUID (Driving under the Influence of Drugs, 
Alcohol and Medicines) project of FP6. 
2. Material and method 
The prevalence of alcohol and other drugs in the driving population was calculated in thirteen 
European countries, see Table 1, based on roadside surveys (Houwing et al., 2011). In total about 50,000 
drivers from the driving population in the participating countries gave a saliva sample, a blood sample or 
both samples.  
The prevalence of alcohol and other drugs in seriously injured and killed car drivers was calculated in 
nine countries, see Table 1, based on studies in hospitals in six countries of seriously injured car drivers 
and studies in four countries of killed car drivers (Isalberti et al., 2011). In total about 2500 injured drivers 
gave a blood sample and about 1000 blood samples from killed drivers that had been collected for the 
accident investigation were included.   
A set of guidelines, both for the roadside surveys and the studies of seriously injured drivers were 
developed and were followed in the national setups of the studies, implying that all blood and saliva 
samples that were collected from the drivers in the studies were analysed with confirmation methods for 
the same number of substances.  
The data collections followed these guidelines, in order to ensure that the roadside surveys consisted of 
a random sample of drivers at all times of the day and week in various locations spread out over the 
regions. As for seriously injured drivers, the guidelines recommended that all seriously injured drivers 
admitted to the participating hospitals that fulfilled a number of criteria were included in the study. 
In order for the roadside survey to serve as the control sample and the data collected in the hospitals to 
serve as the case sample for estimating the risk as calculated by means of odds ratios of a case-control 
study, the regions for the two types of studies should cover the same areas in a country.    
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Table 1. Participating countries, study period and number of samples 
Region Country
Prevalence in the 
driving population 
Period (N)
Prevalence in 
injured drivers  
Period (N)
Prevalence in 
killed drivers 
Period (N)
Risk              
controls/cases
Denmark 2008-2009 (3002) 2007-2010 (840) 3002/839
Finland 2008-2010 (54) 2706/54
Finland 2006-2008 (483) 3841/478
Norway 2008-2009 (9236) 2006-2008 (193) 9236/193
Sweden 2008-2009 (6199) 2008 (157) 6199/156
Czech Republic 2008-2009 (2037)
Hungary 2008-2009 (2738)
Lithuania 2008-2009 (1264) 2008-2010 (387) 1267/385
Poland 2007-2009 (4005)
Spain 2008-2009 (3174)
Italy 2008-2009 (1310) 2008-2009 (676) 1086/676
Portugal 2008-2009 (3965) 2009 (285) 2641/285
Belgium 2008-2009 (2949) 2008-2010 (348) 2949/348
The Netherlands 2007-2009 (4822) 2008-2010 (187) 4822/188
Northern Europe
Eastern Europe
Southern Europe
Western Europe
2007-2009 (3841)
 
2.1. Data collected in the roadside surveys 
A number of regions were selected for the studies in the various countries, depending on the 
willingness of the police to cooperate at the roadside in stopping drivers at random. Only drivers of 
passenger cars and vans (hereafter named drivers) aged 18 and above were included in the road side 
surveys. Drivers were stopped at all times of the day and night in various locations both in urban and rural 
roads. After being stopped by the police, standardised anonymous information on the drivers was 
gathered by research teams and a saliva and/or blood sample was collected. However, in most countries 
where saliva was collected, the alcohol concentration was based on a breathalyzer reading and converted 
to the equivalent blood concentration. The following information was mandatory: age, gender, type of 
vehicle, road type and time and date of the control. The study sample was weighted according to the 
national distribution of traffic in eight time periods of the week, in which the prevalence was assumed not 
to vary substantially. Weighted prevalence was calculated, including confidence intervals (95%). 
2.2. Data collected from seriously injured  drivers 
Five hospitals were selected in Belgium and Denmark, two in Finland, four in Italy and Lithuania and 
three in the Netherlands, preferably in the same regions as the roadside surveys. Only drivers aged 18 and 
above were included in the study. The interval between accident and blood sampling had to be less than 3 
hours in order for the toxicological analyses to reflect as much as possible the drug concentration at the 
time of the accident. Only drivers with a Maximum Abbreviated Injury Scale (MAIS) ≥  2 or equivalent 
were included (AAAM, 2008). A MAIS score was not available in Denmark and Italy, but other criteria 
were considered to guarantee inclusion of patients with an injury severity equivalent to MAIS ≥  2.  
Standardised information on the patients and their accidents was gathered. The following information 
was mandatory: age, gender, type of vehicle and type of accident (single/multi vehicle), time and date of 
accident and of blood sampling, medication/fluids administered prior to blood sampling, MAIS-score. 
Since the study sample included all patients fulfilling the inclusion criteria, the prevalence was 
approximated to the proportion (percentage) of psychoactive substances. 
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2.3. Data collected from killed drivers 
Information on drugs in killed drivers and vans was obtained from the blood samples that had been 
collected in connection to the accident investigation in four countries within a certain period, cf. table 1. 
Blood samples from killed drivers aged 18 and above obtained from traffic accidents in the study periods, 
as well as similar information as for the seriously injured patients formed the data material. The 
prevalence was approximated to the proportion (percentage) of psychoactive substances. 
2.4. Calculation of the risk for a car driver of being seriously injured or killed in a road accident while 
positive for alcohol and other drugs psychoactive substances 
The risk for a driver of getting seriously injured or killed in an accident while positive for a given 
substance was calculated as the ratio between the odds for a driver of being seriously injured/killed in an 
accident while positive for a given substance and the odds of being seriously injured/killed while 
negative. The odds ratios were calculated by means of logistic regression using the SAS 9.2 procedure 
proc logistic with 95% confidence intervals.  
As the case study samples, the data from the hospital studies of seriously injured drivers and the study 
samples of killed drivers were used. As the control study samples, the data from the roadside surveys in 
the same countries, weighted for the national distribution of traffic in each of eight time periods of the 
week were used (Hels et al., 2011). The risk estimates were adjusted by gender, age and country. Six 
countries contributed to the study on the risk of getting seriously injured: Denmark, Finland, Lithuania, 
Italy, Belgium and the Netherlands. Four countries contributed to the study on the risk of getting killed: 
Finland, Norway, Sweden and Portugal.  
In principle, data were only included from regions where both controls and cases were collected. 
However, additional control regions were included if the age and gender distribution was not significantly 
different from the regions where both study samples were collected. In the same way, additional case 
regions were included if the injury score distribution was not significantly different from the regions 
where both study samples were collected. For the number of cases and controls, see table 1. 
2.5. Toxicological analyses 
All blood- and saliva samples were analysed by means of fully validated methods for the same number 
of substances in all countries, cf. table 2, except for alcohol in countries where the breathalyzer reading 
was used. Whole blood samples were extracted using solid phase extraction (SPE) or liquid-liquid (LLE) 
extraction. Chromatographic separation was performed by gas chromatography (GC), High Performance 
liquid chromatography (HPLC) or Ultra Performance liquid chromatography (UPLC). Saliva samples 
were extracted using solid phase extraction (SPE) or liquid-liquid (LLE) extraction. Chromatographic 
separation was performed by gas chromatography (GC), High Performance liquid chromatography 
(HPLC), Ultra Performance liquid chromatography (UPLC) or liquid chromatography (LC). Detection 
was done by mass spectrometry (MS) or tandem mass spectrometry (MSMS). Proficiency test analyses of 
saliva and whole blood were carried out by all participating laboratories, resulting in a high quality of 
toxicological analyses in all countries. 
As the information about whether a subject was positive for a substance or not, came from 
toxicological analyses of samples from both blood and saliva, it was crucial for this study that equivalent 
cut-offs for blood and saliva were developed in order to be able to compare the saliva-positive subjects 
with the blood-positive subjects, see table 2. This is not an ideal solution, but the best alternative taken 
the situation that it was not possible to collect blood in the road side controls in all countries.  
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These equivalent concentrations were developed in the DRUID project (Verstraete et al., 2011) and are 
a most important finding, that partly solves the problem of being able to compare results based on two 
different specimen being collected in the road side survey. This means that concentrations of both blood 
and saliva could be included in the prevalence calculations. Furthermore, it enables the calculation of 
relative risk based on saliva in the control study sample and blood in the case study sample. In countries 
where alcohol was based on breath, the conversion factor between breath and blood was set to 2100. 
The following results are based on concentrations of the substances in question that are equal to or 
exceed the above-mentioned equivalent concentrations in blood and in saliva. If both a saliva sample and 
a blood sample were analysed, the concentration in blood was used for this sample. THCCOOH alone 
was left out since this metabolite cannot be found in saliva. 
 
Table 2 Recommended equivalent cut-offs for the substances included in the studies 
Substance Whole blood (ng/mL)
Saliva 
(ng/mL) Substance
Whole blood 
(ng/mL)
Saliva 
(ng/mL)
Ethanol 0.1 (g/L) 0.082 (g/L)
6-AM 10 16 MDMA 20 270
Alprazolam 10 3.5 Methadone 10 22
Amphetamine 20 360 Methamphetamine 20 410
Benzoylecgonine 50 95 Morphine 10 95
Clonazepam 10 1.7 Nordiazepam 20 1.1
Cocaine 10 170 Oxazepam 50 13
Codeine 10 94 THC 1 27
Diazepam 140 5 Zolpidem 37 10
Flunitrazepam 5.3 1 Zopiclone 10 25
Lorazepam 10 1.1 Tramadol 50 480
MDA 20 220 7-amino-clonazepam 1 3.1
MDEA 20 270 7-amino-flunitrazepam 8.5 1  
 
For the results of the toxicological findings, drugs were grouped according to their pharmacological 
characteristics. Substances of the same type were combined into substance groups (see table 3).  
 
Table 3. Substance groups in the analyses of prevalence and risk 
Substance group
Prevalence in 
the driving 
population 
Prevalence in 
the injured 
population 
Relative risk 
of injury
Alcohol x x x
Amphetamines, methamphetamines and MDA, MDEA and MDMA x x x
Benzoylecgonine x
Cocaine (cocaine or cocaine + benzoylecgonine) x
THC (THC or THC + THCCOOH) x x x
Illicit  opiates x x x
Benzodiazepines x x
Z-drugs x x
Medicinal opioids x x x
Alcohol and drug(s) x x x
Multiple drugs x x x
x
xx
 
 
As for the toxicological findings in seriously injured drivers, in case the blood sample was positive for 
a drug that corresponded to the medicine administered before the blood sample was taken, then this 
concentration was considered negative. 
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3. Results 
3.1. Prevalence of psychoactive substances  in the driving population 
Tables 4 and 5 show the prevalence for the various psychoactive substances and their combinations in 
the driving population in the countries involved, including confidence intervals. For some of the 
substance groups, the prevalence was too low to be calculated.  
Highest prevalence in general was found for alcohol, with highest prevalence in the southern and 
western countries of Europe (2.15%-8.59%). As shown in the tables, there were big differences between 
the prevalence in the various countries. However, it should be noted that the data collection in Finland 
showed bias towards a high non-response rate of alcohol positive drivers, resulting in a too low 
prevalence, whereas the data collection in Italy showed a preference towards including drivers with signs 
of alcohol impairment. Finally drivers who were stopped at the roadside in the Swedish survey and 
registered positive for alcohol above the Swedish alcohol limit were not allowed to be included in the 
control sample by the police. 
The prevalence in the driving population of medicinal drugs was higher in the northern countries 
(1.12%-1.71%) whereas the prevalence of illicit drugs was higher in the southern countries of Europe, 
especially Spain (7.63%).  
However, regarding the prevalence of medicines in northern Europe, there were differences in the 
prevalence between the four countries for the different types of medicines analysed for. In eastern Europe 
the prevalence of alcohol, illicit drugs as well as medicinal drugs was relatively low compared to the 
other European regions. Combined use of alcohol and drugs and multiple drug use were more common in 
the southern countries of Europe. 
THC was the most frequently detected illicit drug in the driving population, followed by cocaine. 
Amphetamines and illicit opiates were less frequently detected. Illicit drugs were in general mainly 
detected among young male drivers, during all times of the day but mainly during the weekend. 
 
Table 4. Prevalence of alcohol and other psychoactive substances in the general driving population in northern and eastern Europe, 
including confidence intervals (95%) 
DK FI NO SE CZ HU LT PL
Alcohol alone 2.53 0.64 0.32 n.a. 0.99 0.15 3.86 1.47
2.02 - 3.15 0.43 - 0.94 0.23 - 0.46 0.65 - 1.53 0.06 - 0.38 2.93 - 5.06 1.14 - 1.9
Illicit drugs alone 0.22 0.12 0.60 0.10 0.82 0.23 0.22 0.71
0.10 – 0.46 0.06 – 0.30 0.46 – 0.78 0.04 – 0.21 0.51 – 1.31 0.11 – 0.49 0.07 – 0.66 0.49 – 1.02
                Amphetamines 0.02 0.05 0.06 0.07 0.36 - 0.22 0.05
0 - 0.16 0.02 - 0.19 0.02 - 0.13 0.03 - 0.17 0.17 - 0.72 - 0.07 - 0.66 0.01 - 0.18
                Cocaine - 0.03 0.06 - - 0.04 - -
- 0.01 - 0.16 0.03 - 0.14 - - 0.01 - 0.21 - -
                THC 0.20 0.04 0.48 0.03 0.46 0.19 - 0.57
0.09 - 0.43 0.01 - 0.17 0.36 - 0.64 0.01 - 0.12 0.25 - 0.86 0.08 - 0.44 - 0.38 - 0.85
                Illicit opiates - - - - - - - 0.09
- - - - - - - 0.04 - 0.25
Medicinal drugs alone 1.58 1.71 1.69 1.12 0.83 1.68 1.41 0.17
1.19 - 2.09 1.35 - 2.17 1.45 - 1.98 0.89 - 1.42 0.52 - 1.33 1.26 - 2.23 0.9 - 2.23 0.08 - 0.35
                Benzodiazepines 0.47 0.79 0.84 0.19 0.62 1.50 1.41 0.14
0.28 - 0.79 0.56 - 1.13 0.67 - 1.05 0.11 - 0.33 0.36 - 1.07 1.11 - 2.03 0.9 - 2.23 0.06 - 0.31
                Z-drugs 0.32 0.36 0.69 0.31 - 0.07 - -
0.17 - 0.59 0.21 - 0.6 0.54 - 0.88 0.2 - 0.48 - 0.02 - 0.26 - -
                Medicinal opioids 0.79 0.56 0.16 0.63 0.21 0.11 - 0.03
0.53 - 1.18 0.37 - 0.85 0.1 - 0.27 0.46 - 0.86 0.08 - 0.52 0.04 - 0.32 - 0.01 - 0.15
Alcohol-Drug combination 0.1 0.08 0.07 n.a. 0.05 - 0.03 -
0.03 - 0.3 0.03 - 0.23 0.03 - 0.15 0.01 - 0.28 - 0 - 0.36 -
Drug-Drug combination 0.06 0.29 0.28 0.12 0.11 0.27 - 0.02
0.02 - 0.24 0.16 - 0.52 0.19 - 0.42 0.06 - 0.25 0.03 - 0.38 0.13 - 0.54 - 0 - 0.14
North East
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Table 5. Prevalence of alcohol and other psychoactive substances in the general driving population in southern and western Europe, 
including confidence intervals (95%) 
European region
Country ES IT PT BE NL
Alcohol alone 3.92 8.59 4.93 6.42 2.15
3.3 - 4.66 7.19 - 10.23 4.29 - 5.64 5.59 - 7.36 1.78 - 2.6
All illicit drugs alone 7.63 2.70 1.57 0.64 2.16
6.76 – 8.61 1.95 – 3.73 1.23 – 2.01 0.41 – 1.00 1.79 – 2.61
             Amphetamines 0.11 - - - 0.19
0.04 - 0.3 - - - 0.1 - 0.36
             Cocaine 1.49 1.25 0.03 0.20 0.30
1.12 - 1.97 0.78 - 2.01 0.01 - 0.16 0.09 - 0.43 0.18 - 0.5
             THC 5.99 1.15 1.38 0.35 1.67
5.22 - 6.87 0.7 - 1.89 1.07 - 1.8 0.19 - 0.64 1.34 - 2.07
             Illicit opiates 0.05 0.30 0.15 0.09 0.01
0.01 - 0.2 0.12 - 0.78 0.07 - 0.33 0.03 - 0.28 0 - 0.09
All medicinal drugs alone 1.59 1.50 2.84 2.99 0.60
1.21 - 2.09 0.97 - 2.31 2.37 - 3.41 2.43 - 3.66 0.42 - 0.87
             Benzodiazepines 1.40 0.97 2.73 2.01 0.40
1.05 - 1.87 0.57 - 1.67 2.27 - 3.29 1.57 - 2.59 0.25 - 0.62
             Z-drugs - - - 0.22 0.04
- - - 0.1 - 0.47 0.01 - 0.15
             Medicinal opioids 0.19 0.53 0.11 0.75 0.16
0.09 - 0.41 0.25 - 1.09 0.04 - 0.27 0.5 - 1.13 0.08 - 0.32
Alcohol-drug combinations 1.14 1.01 0.42 0.31 0.24
0.83 - 1.58 0.59 - 1.71 0.26 - 0.67 0.16 - 0.58 0.13 - 0.42
Drug-drug combinations 0.57 1.22 0.23 0.30 0.35
0.36 - 0.89 0.75 - 1.97 0.12 - 0.44 0.16 - 0.58 0.22 - 0.56
South West
 
The group of benzodiazepines was the most prevalent medicinal drug in drivers in the general  traffic, 
Z-drugs were less prevalent. However, considerable differences between countries were observed. 
Medicinal drugs were in general mainly detected among older female drivers during daytime hours. 
3.2. Prevalence of psychoactive substances in  seriously injured and killed drivers 
Table 6 shows the prevalence for the various psychoactive substances alone and the prevalence of 
combined use in seriously injured and killed drivers in the countries involved, sorted by European region. 
Furthermore, table 7 shows the percentages of samples that were positive for a substance group in 
combination with one or more other substance groups.  
The prevalence of alcohol alone varied between 15 and 30% except for Portugal (38.9%). Alcohol in 
combination with other drugs was found in about 13% of the samples in Belgium down to about 2% in 
Lithuania. Among the positive drivers – both seriously injured and killed, the majority had a blood 
alcohol concentration equal to or above 0.5 g/L; the median concentration was 1.6 g/L. 
The prevalence of illicit drugs varied between the countries with considerable combined use of various 
substances. Furthermore, the following remarks characterize illicit drug use: Amphetamine use appeared 
to be more common in northern Europe, both for seriously injured and killed drivers. In Portugal, no 
killed drivers were positive for amphetamines. Cocaine use seemed to be more prevalent in southern 
Europe and for killed drivers in Sweden. In Finland neither any seriously nor killed drivers were positive 
for cocaine.  
Medicinal opioids were found in all countries, with a maximum for seriously injured drivers in 
Lithuania (app 6% alone and 2% in combination with other drugs) and a minimum in the Netherlands 
(app 0.5%, only found alone). Lithuania had almost a double percentage of seriously injured drivers who 
were positive for medicinal opioids (close to 6%), compared to the other five countries. Similarly, 
Sweden had a double percentage of killed drivers who were positive for medicinal opioids compared with 
the other three countries. 
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Table 6. Percentage of seriously injured and killed drivers positive for substance groups alone or their combinations 
European region East South South
Country DK FI LT IT BE NL FI NO S PT
Alcohol alone 14.1 25.5 15.3 18.5 30.2 25.3 24.4 18.2 15.6 38.9
All illicit drugs alone 1.6 1.9 1.1 3.6 2.4 2.7 0.7 3.0 3.4 0
     Amphetamines 1.0 0 0.3 0 0.9 1.1 0.7 1.2 2.1 0
     Cocaine 0 0 0.6 1.3 0 1.1 0 0 0 0
     THC 0.6 2.1 0.3 1.6 1.5 0.5 0 1.8 0.7 0
     Illicit opiates 0 0 0 0.7 0 0 0 0 0 0
All medicinal drugs alone 4.2 1.9 8.0 2.2 4.2 1.0 8.6 3.6 3.5 1.4
     Benzodiazepines 1.2 0 2.3 0.4 1.5 0 5.2 1.8 0 0.7
     Z-drugs 0.5 2.1 0 0 0.9 0.5 1.7 1.2 2.8 0
     Medicinal opioids 2.5 0 5.7 1.8 1.2 0.5 1.5 0.6 0.7 0.7
Alcohol-Drug combination 5.4 10.6 2.3 4.6 13.2 4.3 7.2 7.9 4.3 6.0
Drug-Drug combination 3.5 4.3 0.8 2.5 2.5 0.5 1.5 7.3 4.3 0.4
Positive samples in total 28.8 44.2 27.5 31.4 52.5 33.8 42.4 40.0 31.1 46.7
Seriously injured drivers Killed drivers
North West North
 
Table 7 Percentage of seriously injured drivers positive for one substance group in combination with other substance groups  
European region East South South
Country DK FI LT IT BE NL FI NO S PT
Amphetamines 3.2 3.7 0.3 0.1 1.7 1.1 1.5 6.3 3.9 0
Cocaine 1.3 0 0 4.2 3.8 3.7 0 0.6 1.3 1.4
THC 0.7 3.8 0.3 2.1 6.1 0 1.3 4.5 0.7 0
Illicit opiates 0.5 0 0.3 1.3 0.6 0 0 0 0 0
Benzodiazepines 5.5 10.2 1.3 0.3 5.8 0 7.9 8.0 3.9 1.1
Z-drugs 0.7 1.9 0 0 0.9 0 1.3 2.7 0.6 0
Medicinal opioids 1.7 2.0 2.1 1.9 1.5 0 0.6 1.1 2.7 1.4
North West North
Seriously injured drivers Killed drivers
 
3.3. Risk of getting seriously injured or killed  
 
Risk estimates based on data from several countries for seriously injured drivers and killed drivers are 
shown in table 8 and 9. Both crude odds ratios as well as odds ratios adjusted for gender, age and country 
were calculated. However, as indicated in tables 8 and 9, Finland and Italy were left out of the risk 
calculation regarding alcohol due to suspected bias in the data collection of drivers at the roadside, and 
Sweden because alcohol positive drivers were not included in the control sample, see section 3.1.  
As seen from table 8 and 9, the main problem is high alcohol concentrations and alcohol combined 
with other psychoactive substances. Other high risk groups are medium alcohol concentrations 0.8-1.2, 
multiple drug use and amphetamines. Medium increased risk was found for alcohol concentrations 0.5 - 
0.8 g/L, for cocaine and for the medicinal drug groups included in the study. The risk associated with 
benzoylecgonine that is not an active agent might be caused by sleep deprivation after cocaine 
consumption. Furthermore, the risk associated with THC seems to be similar to the risk when driving 
with a low alcohol concentration. The risk estimates for some of the illicit drugs vary to a high degree 
among the single countries whereas risk estimates for other illicit drugs are based on few positive samples 
with the result of very wide confidence intervals. Therefore the risk estimates for illicit drugs should be 
handled with care. Young drivers aged 18-24 had the highest risk. For seriously injured drivers, the risk 
was lowest in the Netherlands and Finland and highest in Italy. For killed driver, it was lowest in Norway 
and highest in Finland and Portugal. The trend was the same for all substance groups.  
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Table 8. Risk (odds ratio) for a driver of getting seriously injured while positive for various substances including confidence 
intervals (95%). Crude OR and OR adjusted for gender, age and country. 
Substance group Countries Crude OR C.I. Adjusted OR C.I.
Negative (reference) 1.00 1.00
All alcohol DK, LT, BE, NL 7.55 6.47-8.80 9.79 8.18-11.72
     0.1g/L≤alcohol<0.5g/L DK, LT, BE, NL (1.05) 0.73-1.53 (1.30) 0.88-1.94
     0.5g/L≤alcohol<0.8g/L DK, LT, BE, NL 3.80 2.48-5.82 4.18 2.58-6.77
     0.8/L≤alcohol<1.2g/L DK, LT, BE, NL 13.97 8.75-22.29 16.48 9.64-28.18
     Alcohol≥1.2g/L DK, LT, BE, NL 55.27 39.52-77.31 77.76 54.11-111.74
All illicit drugs alone DK, FI, IT, LT, BE, NL 2.87 2.12-3.89 2.68 1.88-3.82
     Amphetamines DK, FI, IT, LT, BE, NL 9.66 4.80-19.46 14.15 5.82-34.42
     Benzoylecgonine DK, FI, IT, LT, BE, NL 5.36 2.53-11.34 3.88 1.41-10.68
     Cocaine DK, FI, IT, LT, BE, NL 3.41 1.61-7.21 (1.65) 0.66-4.16
     THC DK, FI, IT, LT, BE, NL 1.86 1.20-2.88 1.91 1.15-3.17
     Illicit opiates DK, FI, IT, LT, BE, NL 4.03 1.32-12.32 (1.18) 0.23-5.99
All medicinal drugs alone DK, FI, IT, LT, BE, NL 3.60 2.84-4.57 3.60 2.74-4.74
     Benzodiazepines and Z-drugs DK, FI, IT, LT, BE, NL 1.73 1.19-2.51 1.77 1.16-2.69
     Medicinal opioids DK, FI, IT, LT, BE, NL 7.99 5.73-11.15 7.37 4.99-10.88
Alcohol-Drug combination DK, LT, BE, NL 31.97 20.76-49.25 39.15 24.21-63.31
Drug-Drug combination DK, FI, IT, LT, BE, NL 8.64 5.85-12.75 7.02 4.38-11.24
 
Table 9. Risk (odds ratio) for a driver of getting killed while positive for various substances, including confidence intervals (95%). 
Crude OR and OR adjusted for gender, age and country. 
Substance group Countries Crude OR C.I. Adjusted OR C.I.
Negative (reference) 1.00 1.00
All alcohol N, PT 37.64 29.36-48.24 19.00 14.43-25.03
     0.1g/L≤alcohol<0.5g/L N, PT 9.23 6.07-14.05 3.62 2.32-5.65
     0.5g/L≤alcohol<0.8g/L N, PT 42.94 21.99-83.86 22.96 11.24-46.91
     0.8/L≤alcohol<1.2g/L N, PT 34.81 16.02-75.65 19.97 8.52-46.77
     Alcohol≥1.2g/L N, PT 450.37 224.06-905.25 353.11 164.63-757.40
All illicit drugs alone FI, N, S, PT 3.85 2.17-6.80 3.59 1.95-6.60
     Amphetamines FI, N, S, PT 25.44 10.81-59.90 34.34 13.18-89.49
     Benzoylecgonine FI, N, S, PT 6.87 1.49-31.76 - -
     Cocaine FI, N, S, PT 22.34 3.66-136.53 - -
     THC FI, N, S, PT (1.80) 0.73-4.44 (1.25) 0.45-3.51
     Illicit opiates FI, N, S, PT 10.04 2.04-49.32 - -
All medicinal drugs alone FI, N, S, PT 5.05 3.80-6.72 4.47 3.31-6.05
     Benzodiazepines and Z-drugs FI, N, S, PT 5.11 3.72-7.02 4.59 3.28-6.43
     Medicinal opioids FI, N, S, PT 4.82 2.61-8.88 4.07 2.14-7.72
Alcohol-Drug combination N, PT 41.22 22.59-75.24 25.19 13.06-48.59
Drug-Drug combination FI, N, S, PT 16.77 9.95-28.27 24.42 13.79-43.25
 
4. Conclusions 
Alcohol and illicit drugs in the general driving population were more prevalent in southern and 
western Europe whereas medicines were more prevalent in northern Europe. These findings are in line 
with the prevalence of psychoactive substances in the general population (Ravera and de Gier 2008).   
Alcohol was most prevalent both for seriously injured and killed drivers, with the blood alcohol 
concentration ≥ 0.5 g/L in about 90% of the samples. In both studies, the majority of illicit and medicinal 
drugs appeared to be used in combination with other psychoactive substances. Among the illicit drugs, 
amphetamine use appeared to be more common in northern Europe, while cocaine use seemed to be more 
prevalent in southern Europe. Compared to the present study, former studies found even higher 
prevalence of benzodiazepines and cannabis in injured drivers (Mura 2003, Assum et al. 2005).   
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High alcohol concentrations and the combination of alcohol and other drugs showed the highest risk 
and reflect that in contrary to the driving population, alcohol was found in high concentrations in accident 
involved drivers. These findings are in line with previous case-control studies (Borkenstein et al. 1974, 
Krüger and Vollrath 2004, Mathijssen and Houwing 2005) that showed that the accident and injury risk 
increases drastically at high BAC levels.  
Emphasis should also be on the high risk for multiple drug use that was much more common in 
accidents than in drivers in traffic. In general, the risk of the various drug groups show values that are 
significantly above 1. 
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